Human Health Division (HHD) Products

Product List by Therapeutic
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nabumetone

Composition:

  • Nabuton 500: Each film-coated tablet contains Nabumetone BP 500 mg.
  • Nabuton 750: Each film-coated tablet contains Nabumetone BP 750 mg.

Indication:
For the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Dosage & Administration:

  • Recommended starting dose: 1000 mg once daily with or without food.
  • For enhanced relief, doses up to 1500–2000 mg per day may be given as a single or divided dose.
  • Renal Impairment: Start with a reduced dose (500–750 mg daily) as directed by a physician.

Lornoxicam

Composition

Loxodol 4: Each film coated tablet contains Lornoxicam INN 4 mg. Loxodol 8: Each film coated tablet contains Lornoxicam INN 8 mg.

Indications

Indicated for the treatment of mild to moderate pain in osteoarthritis, surgery, sciatica and other inflammations.

Dosage & Administration

For Pain relief: In Adult: 8-16 mg daily in 2-3 divided doses. Max: 16 mg daily. 

In Osteoarthritis & Rheumatoid arthritis: Adult: 12 mg daily in 2-3 divided doses, up to 16 mg daily if needed. 

For patients with renal/liver impairment: Maximum 12 mg daily in 2-3 divided doses.

It should be taken 1 hour before meal or 2 hours after meal to minimize gastrointestinal irritation or as directed by the physician.

Momeasone

Composition:

Momespray™: Each spray contains Mometasone Furoate BP 50 meg.


Indication:

Momespray™ is indicated for the treatment of the nasal symptoms of seasonal and perennial allergic rhinitis, in adults and pediatric patients 2 years of age and older. It

is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older. It is also indicated for the treatment of

nasal polyps in patients 18 years and older.


Dose & Administration:

Administer Mometasone Nasal Spray by the intranasal route only.

Allergic Rhinitis

Adults and Children 12 Years of Age and Older: For prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of the nasal

symptoms of perennial allergic rhinitis use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg). In patients

with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis use Momespray™ 50 meg (200 meg/day) 2 to 4 weeks prior

to the anticipated start of the pollen season.


Children (2 to 11 years of age) For treatment of the nasal symptoms of seasonal and perennial allergic rhinitis use one spray (50 meg of Mometasone Furoate in each spray) in each nostril once daily (total daily dose of 100 meg).

Nasal Polyps

Adults 18 years of Age and Older: For nasal polyps use two sprays (50 meg of Mometasone Furoate in each spray) in each nostril twice daily (total daily dose of 400

meg). A dose of two sprays (50 meg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 meg) is also effective in some patients.


Fluticasone Propionate + Azelastine

Composition:
Flutispray™ Plus: Each spray delivers Fluticasone Propionate BP 50 meg and Azelastine hydrochloride BP 137 meg.

Indication:
Flutispray™ Plus is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both Azelastine Hydrochloride and Fluticasone Propionate for symptomatic relief.

Dose and Administration:
The recommended dosage of Flutispray™ Plus is one spray in each nostril twice daily.

Fluticasone Propionate

Composition:
Flutispray™ Nasal Spray: Each spray contains
Fluticasone Propionate BP 50 meg.

Indication:
Flutispray™ is indicated for the management of the nasal symptoms of seasonal & perennial allergic & non-allergic rhinitis in adults and paediatric patient 4 years of age and older.

Dose & Administration:
Adults 02 (two) sprays in each nostril once daily, preferably in the morning.
In some cases, 02 (two) sprays in each nostril twice daily may be required or as directed by the physician.
Total daily doses of 200 meg (04 sprays) should not generally be exceeded.
Children (4 to 11 years of age) 01 (one) spray in each nostril once daily. In some cases, 01 (one) spray in each nostril twice daily may be required or as directed by the physician.
Total daily doses of 100 meg (2 sprays) should not generally be exceeded or as directed by the physicians

Etoricoxib

COMPOSITION
Torcox™ 60 Tablet : Each film coated tablet contains Etoricoxib INN 60 mg.
Torcox™ 90 Tablet : Each film coated tablet contains Etoricoxib INN 90 mg.
Torcox™ 120 Tablet : Each film coated tablet contains Etoricoxib INN 120 mg.

INDICATION
Torcox™ (Etoricoxib) is indicated for relief of pain and inflammation in -
• Osteoarthritis
• Rheumatoid arthritis
• Ankylosing spondylitis
• Other chronic musculoskeletal disorders
• Acute gout
• Primary dysmenorrhoea &
• Dental pain

DOSE AND ADMINISTRATION
Pain and inflammation in Osteoarthritis:
• Child 16-17 years: 30 mg once daily, increased if necessary to 60 mg once daily
• Adult: 30 mg once daily, increased if necessary to 60 mg once daily. Pain and inflammation in rheumatoid arthritis & Ankylosing spondylitis:
• Child 16-17 years: 60 mg once daily, increased if necessary to 90 mg once daily.
  Adult: 60 mg once daily, increased if necessary to 90 mg once daily.
Acute gout:
• Child 16-17 years: 120 mg once daily for maximum 8 days
• Adult: 120 mg once daily for maximum 8 days
Dental pain:
• 90-120 mg once daily for maximum 8 days.
Primary dysmenorrhoea
• 120 mg once daily for maximum 8 days
or as directed by the physician

Naproxen + Esomeprazole

Composition
Esona 375/20 Tablet: Each tablet contains Naproxen BP 375 mg & Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg.
Esona 500/20 Tablet: Each tablet contains Naproxen BP 500 mg & Esomeprazole Magnesium Trihydrate USP equivalent to Esomeprazole 20 mg.

Indication
It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, dysmenorrhoea and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID associated gastric ulcers.

Dosage and Administration
Carefully consider the potential benefits and risks of Esona and other treatment options before deciding to use Esona. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. If a dose of Esomeprazole lower than a total daily dose of 40 mg is more appropriate, a different treatment should be considered.

Esona 375/20 & Esona 500/20, 1 tablet twice daily.

Do not split, chew, crush or dissolve the tablet. Esona is to be taken at least 30 minutes before meals or as directed by the physician.